The use of compounded peptides is under scrutiny. These peptides are short-chain amino acids that can aid in reducing inflammation and improving sleep.

The FDA has placed certain peptides on a restrictive list, citing concerns over safety. A legal challenge to this decision is underway, led by EVEXIAS Life Sciences.

Further details on the FDA's decision and the ongoing legal battle are available through FOX 26 Houston.